
HIVE Stock Forecast & Price Target
HIVE Analyst Ratings
Bulls say
HIVE Digital Technologies is set to experience a significant increase in ARR growth, with funding in place to scale up to $200 million this year. Although headwinds from lower hash price and timing of deployments affected F4Q26 results, HIVE's HPC business is expected to ramp up quickly and drive re-rating of the stock. F2026 results saw total revenues of $297.8 million, with HIVE doubling its BTC production and generating $72.9 million of adjusted EBITDA. The company's GPU cloud business is nearing a major inflection point, presenting an attractive risk/reward potential with the ability to secure lucrative AI cloud contracts. With potential for a large cloud deal, there is strong potential for valuation re-rating, and the current market cap of $1.2 billion only values the company's BTC mining operations. However, operational execution and technological risks, dependence on Bitcoin prices, competition, capital raising, and uncertain regulatory environment remain key risks for the company's future performance. Overall, with a target price of $4.60 and a sum-of-the-parts valuation approach, HIVE Digital Technologies presents a promising investment opportunity.
Bears say
HIVE Digital Technologies is facing negative factors such as a volatile cryptocurrency market, unpredictable energy costs, and cybersecurity concerns that could impact their revenue and profitability. Their recent expansion plans have also put them at risk for shareholder dilution and reliance on equity raises. While their HPC business has potential with contracts and partnerships in place, it has experienced delays in deployment and underperformed in revenue. Therefore, the company's revenue and profitability may continue to be impacted in the near-term, leading to a negative outlook on the stock.
This aggregate rating is based on analysts' research of Hive Blockchain Technologies Ltd and is not a guaranteed prediction by Public.com or investment advice.
HIVE Analyst Forecast & Price Prediction
Start investing in HIVE
Order type
Buy in
Order amount
Est. shares
0 shares